相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2Akita mouse
Rute S. Araujo et al.
EXPERIMENTAL EYE RESEARCH (2020)
PlGF silencing combined with PEDF overexpression: Modeling RPE secretion as potential therapy for retinal neovascularization
Rute S. Araujo et al.
MOLECULAR BIOLOGY REPORTS (2020)
Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
Richard Filek et al.
CLINICAL OPHTHALMOLOGY (2019)
Intravitreal AAV2.COMP-Ang1 Attenuates Deep Capillary Plexus Expansion in the Aged Diabetic Mouse Retina
Lara S. Carroll et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases
Quan Dong Nguyen et al.
ACTA OPHTHALMOLOGICA (2018)
The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration
Christine Altmann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Pathophysiology of Diabetic Retinopathy: The Old and the New
Sentaro Kusuhara et al.
DIABETES & METABOLISM JOURNAL (2018)
Neutralization of placental growth factor as a novel treatment option in diabetic retinopathy
Tine Van Bergen et al.
EXPERIMENTAL EYE RESEARCH (2017)
Gene therapy for diabetic retinopathy: Are we ready to make the leap from bench to bedside?
Jiang-Hui Wang et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Biomarkers of Diabetic Retinopathy
Daniel Shu Wei Ting et al.
CURRENT DIABETES REPORTS (2016)
pEPito-driven PEDF Expression Ameliorates Diabetic Retinopathy Hallmarks
Sofia M. Calado et al.
HUMAN GENE THERAPY METHODS (2016)
PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases
Xuemin He et al.
CLINICAL SCIENCE (2015)
Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2Akita diabetic mouse
Jose R. Hombrebueno et al.
SCIENTIFIC REPORTS (2015)
Deletion of Placental Growth Factor Prevents Diabetic Retinopathy and Is Associated With Akt Activation and HIF1 alpha-VEGF Pathway Inhibition
Hu Huang et al.
DIABETES (2015)
Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy
M. B. Sasongko et al.
DIABETIC MEDICINE (2015)
Protective Effects of Antiplacental Growth Factor Antibody Against Light-Induced Retinal Damage in Mice
Hiroshi Izawa et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Angiogenic and Inflammatory Vitreous Biomarkers Associated With Increasing Levels of Retinal Ischemia
Kyle Kovacs et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Modern retinal laser therapy
Igor Kozak et al.
SAUDI JOURNAL OF OPHTHALMOLOGY (2015)
Aqueous humour levels of placental growth factor in diabetic retinopathy
Ryo Ando et al.
ACTA OPHTHALMOLOGICA (2014)
Neuronal Cell Death in the Inner Retina and the Influence of Vascular Endothelial Growth Factor Inhibition in a Diabetic Rat Model
Hae-Young Lopilly Park et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
Steven F. Abcouwer et al.
YEAR IN DIABETES AND OBESITY (2014)
A review of anti-VEGF agents for proliferative diabetic retinopathy
P. Osaadon et al.
EYE (2014)
Sustained Gene Expression in the Retina by Improved Episomal Vectors
Sofia M. Calado et al.
TISSUE ENGINEERING PART A (2014)
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
K. Ghasemi Falavarjani et al.
EYE (2013)
Retinal Angiogenesis in the Ins2(Akita) Mouse Model of Diabetic Retinopathy
Zongchao Han et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy
Rob J. Van Geest et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse
William S. Wright et al.
EXPERIMENTAL EYE RESEARCH (2012)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
Long-Term Retinal PEDF Overexpression Prevents Neovascularization in a Murine Adult Model of Retinopathy
Virginia Haurigot et al.
PLOS ONE (2012)
CYTOKINE CONCENTRATION IN AQUEOUS HUMOR OF EYES WITH DIABETIC MACULAR EDEMA
Jost B. Jonas et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
The RESTORE Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema
Paul Mitchell et al.
OPHTHALMOLOGY (2011)
A Computational Tool for Quantitative Analysis of Vascular Networks
Enrique Zudaire et al.
PLOS ONE (2011)
Managing diabetic macular edema: The leading cause of diabetes blindness
Pedro Romero-Aroca
WORLD JOURNAL OF DIABETES (2011)
Characterization of a Mouse Model of Hyperglycemia and Retinal Neovascularization
Elizabeth P. Rakoczy et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
pEPito: a significantly improved non-viral episomal expression vector for mammalian cells
Rudolf Haase et al.
BMC BIOTECHNOLOGY (2010)
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Pascale Massin et al.
DIABETES CARE (2010)
Steroids as Part of Combination Treatment: The Future for the Management of Macular Edema?
F. Bandello et al.
OPHTHALMOLOGICA (2010)
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2010)
DOSE OF INTRAVITREAL BEVACIZUMAB (AVASTIN) USED AS PREOPERATIVE ADJUNCT THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY
Takayuki Hattori et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy
Siamak Moradian et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
J. F. Arevalo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy
N. Miyamoto et al.
DIABETOLOGIA (2007)
Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats
Sho-ichi Yamagishi et al.
OPHTHALMIC RESEARCH (2007)
Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy
John O. Mason et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
Robert L. Avery et al.
OPHTHALMOLOGY (2006)
Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy
Sarah X. Zhang et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2006)
The Ins2Akita mouse as a model of early retinal complications in diabetes
AJ Barber et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Electroporation and RNA interference in the rodent retina in vivo and in vitro
T Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection
E Storkebaum et al.
BIOESSAYS (2004)
Diabetic retinopathy
RN Frank
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Epidemiology of diabetic retinopathy and macular oedema: a systematic review
R Williams et al.
EYE (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats
S Roy et al.
DIABETES (2003)
ABC of diabetes - Retinopathy
PJ Watkins
BRITISH MEDICAL JOURNAL (2003)
Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy
N Ogata et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization
K Mori et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
P Carmeliet et al.
NATURE MEDICINE (2001)
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization
GQ Gao et al.
FEBS LETTERS (2001)
Effect of cyclosporin-A on the blood-retinal barrier permeability in streptozotocin-induced diabetes
A Carmo et al.
MEDIATORS OF INFLAMMATION (2000)
分享论文
